High Patient Satisfaction
Superior Patient Outcomes
Personalized 24 Month Follow-up
85% of our patients report statistically significant improvments post-treatment. Efficacy results are quantified by measuring changes in unique inflammatory markers in conjunction with subjective data provided in PAR-Q vitality questionnaires. We follow-up with patients ever 3 months for 24 months post-infusion.